Literature DB >> 24529114

Leptin and coronary heart disease: a systematic review and meta-analysis.

San-Bao Chai1, Feng Sun2, Xiao-Lu Nie3, Jun Wang4.   

Abstract

INTRODUCTION: Leptin, an adipose tissue-derived hormone, plays a central role in regulating human energy homeostasis. The role of leptin in regulating blood pressure, activating the sympathetic nervous system, insulin resistance, platelet aggregation, arterial thrombosis, angiogenesis, and inflammatory vascular responses suggests that leptin may have a close relationship with the development of coronary heart disease (CHD). However, no conclusive data are available to determine the association between leptin and CHD.
METHODS: The PubMed, EMBASE and Cochrane databases were surveyed for original studies describing the association between leptin and CHD outcome from the date of publication of each database through March 2013. The data were extracted by two investigators independently.
RESULTS: The meta-analysis reported here was comprised of eight original articles with a total of 21,064 participants (10,842 men, 10,222 women) and 2053 CHD events. The odds ratio for the sociodemographic-adjusted study reported here was 1.57 (95% confidence interval, 1.14-2.16) and 1.72 (95% confidence internal, 1.03-2.87) in males and females, respectively. Further adjustment for additional cardiovascular risk factors resulted in an odds ratio of 1.36 (95% confidence interval, 0.98-1.88) in males and 1.50 (95% confidence interval, 0.93-2.42) in females. Sensitivity analysis restricted to sociodemographics-adjusted studies with high methodological quality indicated an estimate of 1.47 (95% confidence internal, 1.06-2.04) in males and 1.85 (95% confidence internal, 0.61-5.63) in females. Sensitivity analysis restricted to cardiovascular risk factor-adjusted studies showed no significant differences in both males and females.
CONCLUSION: The results of the meta-analysis represents the most precise and accurate estimate of the relationship between leptin and CHD. Although the associations of leptin and CHD were not statistically significant both in male and female overall, males with high levels of leptin should be paid more attention to. Our findings highlight the need for additional well-designed and gender-specific prospective studies to evaluate the role of leptin on the development of CHD.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; Leptin; Meta-analysis

Mesh:

Substances:

Year:  2013        PMID: 24529114     DOI: 10.1016/j.atherosclerosis.2013.11.069

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  16 in total

1.  Impact of adiposity on cellular adhesion: The Multi-Ethnic Study of atherosclerosis (MESA).

Authors:  Mary J Christoph; Matthew A Allison; James S Pankow; Paul A Decker; Phillip S Kirsch; Michael Y Tsai; Michele M Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Cecilia Berardi; Christina L Wassel; Nicholas B Larson; Suzette J Bielinski
Journal:  Obesity (Silver Spring)       Date:  2015-12-06       Impact factor: 5.002

Review 2.  Obstructive Sleep Apnea, Hypertension, and Cardiovascular Risk: Epidemiology, Pathophysiology, and Management.

Authors:  Liann Abu Salman; Rachel Shulman; Jordana B Cohen
Journal:  Curr Cardiol Rep       Date:  2020-01-18       Impact factor: 2.931

3.  Dietary patterns and cardiometabolic and endocrine plasma biomarkers in US women.

Authors:  Hala B AlEssa; Vasanti S Malik; Changzheng Yuan; Walter C Willett; Tianyi Huang; Frank B Hu; Deirdre K Tobias
Journal:  Am J Clin Nutr       Date:  2016-12-14       Impact factor: 7.045

4.  Association of serum leptin with angiographically proven cardiovascular disease and with components of the metabolic syndrome: a cross-sectional study in East Azerbaijan.

Authors:  Nafiseh Khanbabaei; Hossein Mozafar Saadati; Shahnam Valizadeh Shahbazloo; Reyhaneh Hoseinpoor; Seyed Hossein Naderi; Roya Taghvamanesh; Sakhavat Abolhasani
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-08-13

5.  Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study.

Authors:  Ekim Seven; Lise L N Husemoen; Thomas S G Sehested; Hans Ibsen; Kristian Wachtell; Allan Linneberg; Jørgen L Jeppesen
Journal:  PLoS One       Date:  2015-06-02       Impact factor: 3.240

6.  Inhibition of leptin-induced vascular extracellular matrix remodelling by adiponectin.

Authors:  Zhi Zhang; Fang Wang; Bing-Jian Wang; Guang Chu; Qunan Cao; Bao-Gui Sun; Qiu-Yan Dai
Journal:  J Mol Endocrinol       Date:  2014-06-30       Impact factor: 5.098

Review 7.  Leptin concentration and risk of coronary heart disease and stroke: A systematic review and meta-analysis.

Authors:  Han Yang; Wenzhi Guo; Jie Li; Shengli Cao; Jiakai Zhang; Jie Pan; Zhihui Wang; Peihao Wen; Xiaoyi Shi; Shuijun Zhang
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

Review 8.  The New Kid on the Block: The Mechanisms of Action of Hyperleptinemia in Coronary Artery Disease and Atherosclerosis.

Authors:  Vernicia Hernandez; Kavaljeet Kaur; Mohamed W ElSharief; Sari W Al Hajaj; Ahmed M Ebrahim; Mirash Razack; David Dragas
Journal:  Cureus       Date:  2021-06-20

9.  Apple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE-/- Mice through the ROS/MAPK/NF-κB Pathway.

Authors:  Zhe-Rong Xu; Jin-You Li; Xin-Wei Dong; Zhong-Ju Tan; Wei-Zhen Wu; Qiang-Min Xie; Yun-Mei Yang
Journal:  Nutrients       Date:  2015-08-24       Impact factor: 5.717

10.  Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism.

Authors:  Isaac Subirana; Montserrat Fitó; Oscar Diaz; Joan Vila; Albert Francés; Eva Delpon; Juan Sanchis; Roberto Elosua; Daniel Muñoz-Aguayo; Irene R Dégano; Jaume Marrugat
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.